Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adjudicated, adolescent, ahead, alongside, appeal, arbitrage, arbitrarily, arbitrary, archived, Arrowhead, Asa, attrition, Aviceda, awaiting, Belite, beneficiary, BLA, bolster, boost, Bulletin, Canadian, capriciously, caption, certiorari, chose, CODM, commensurate, compact, compensatory, complaint, Consortium, constitutionality, contrary, Cowen, crossed, curve, decree, destined, disaggregated, dismissed, doctor, dysfunctional, East, effectuated, enjoined, Erosion, escalation, exact, expert, Fabhalta, FY, FYs, GB, GloBE, guideline, head, highlighting, HTA, infeasible, instruction, Izervay, Jersey, Judith, magnitude, Merck, Michigan, Middle, mifepristone, mobile, morale, motion, navigate, Nevada, nonsubfoveal, notional, Ocugen, OECD, onsite, organizational, Parliament, password, path, pave, PAYGO, PHI, PhRMA, PIE, plaintiff, Postmarketing, preexisting, preparatory, print, purported, quantitative, Ray, reconciling, resurgence, sequestration, Soderberg, stay, stayed, strongly, sue, TCA, thereon, threshold, topline, transposed, truthful, TV, unbiased, uncompensated, unexpired, unmarketability, unscheduled, unwind, unwinding, USPI, vigorously, Washington, Windsor, writ
Removed:
agglutinate, alkylating, Amylyx, ARC, ascending, ASU, avacopan, Avanir, bilirubin, biology, blinded, breathing, calculate, calculating, calibrated, CFI, ChemoCentryx, clinic, clonal, closed, clump, commencing, Conference, confirmation, continually, continuation, convince, COSO, COVID, descent, devastating, dextromethorphan, disrupted, edaravone, elderly, elevated, exhaust, expression, fallen, FFCR, Gyroscope, half, Hb, histopathological, hoc, host, IgM, immunoglobin, IMPD, installment, intravenously, ITF, Iveric, Japanese, junction, logistical, missed, Mitsubishi, modifying, motor, movement, muscle, nerve, neurodegenerative, neuroinflammation, neurological, neuromuscular, Nuedexta, offshore, opening, outbreak, PADDOCK, participant, Patch, paused, PD, PHAROAH, PK, PLAUDIT, prioritization, productivity, Radicava, rank, reclassified, recruit, redirect, remeasured, remotely, repatriated, repealing, retroactively, revealed, riluzole, rollforward, Sanofi, scenario, sooner, speaking, spiked, splenectomy, sporadic, spread, stroke, sublicensee, Subtopic, sulfate, suspended, swallowing, Tanabe, temporarily, thickened, Tiglutik, toxicological, transitioned, unprotected, unwilling, upcoming, walking, worker, worsening
Filing tables
Filing exhibits
Associated APLS transcripts
APLS similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Â
We consent to the incorporation by reference in Registration Statement Nos. 333-269899, 333-
235830 and 333-229091 on Form S-3 and Registration Statement Nos. 333-229876, 333-221528,
333-236708, 333-236710, 333-253518, 333-263100 and 333-269888 on Form S-8 of our reports
dated February 27, 2024, relating to the financial statements of Apellis Pharmaceuticals, Inc. and its
subsidiaries and the effectiveness of Apellis Pharmaceuticals, Inc. and its subsidiaries’ internal control
over financial reporting appearing in this Annual Report on Form 10-K for the year ended December
31, 2023.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
February 27, 2024